DK360287D0 - Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf - Google Patents

Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf

Info

Publication number
DK360287D0
DK360287D0 DK360287A DK360287A DK360287D0 DK 360287 D0 DK360287 D0 DK 360287D0 DK 360287 A DK360287 A DK 360287A DK 360287 A DK360287 A DK 360287A DK 360287 D0 DK360287 D0 DK 360287D0
Authority
DK
Denmark
Prior art keywords
torasemide
aqueous
present
solution
preparable
Prior art date
Application number
DK360287A
Other languages
English (en)
Other versions
DK360287A (da
DK174624B1 (da
Inventor
Fritz Demmer
Werner Gruber
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK360287D0 publication Critical patent/DK360287D0/da
Publication of DK360287A publication Critical patent/DK360287A/da
Application granted granted Critical
Publication of DK174624B1 publication Critical patent/DK174624B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ink Jet (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK198703602A 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf DK174624B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623620 1986-07-12
DE19863623620 DE3623620A1 (de) 1986-07-12 1986-07-12 Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
DK360287D0 true DK360287D0 (da) 1987-07-10
DK360287A DK360287A (da) 1988-01-13
DK174624B1 DK174624B1 (da) 2003-07-28

Family

ID=6305087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703602A DK174624B1 (da) 1986-07-12 1987-07-10 Sprøjteklare, vandige, alkaliske injektionsopløsninger af torasemid og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US4861786A (da)
EP (1) EP0253226B1 (da)
JP (1) JPS6323818A (da)
KR (1) KR950010158B1 (da)
AT (1) ATE53296T1 (da)
AU (1) AU578562B2 (da)
CA (1) CA1302278C (da)
DE (2) DE3623620A1 (da)
DK (1) DK174624B1 (da)
ES (1) ES2016306B3 (da)
FI (1) FI87993C (da)
GR (1) GR3000534T3 (da)
NZ (1) NZ221026A (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
JP3028171B2 (ja) * 1993-08-31 2000-04-04 日本ピラー工業株式会社 複合ガスケット
US6228873B1 (en) 1994-12-09 2001-05-08 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5763491A (en) * 1994-12-09 1998-06-09 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
AU781461C (en) 1999-08-11 2006-02-23 Teva Pharmaceutical Industries Ltd. Torsemide polymorphs
AU2001247592B2 (en) 2000-03-20 2005-08-18 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
EP1465596A1 (en) * 2002-01-18 2004-10-13 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20100053852A1 (en) * 2008-09-02 2010-03-04 Cheng Uei Precision Industry Co., Ltd. Display Device
CN103371967A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 呋塞米注射液及其制剂工艺
JP6415535B2 (ja) * 2013-04-05 2018-10-31 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CA3128033A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
CN110606826B (zh) * 2019-05-23 2021-06-01 上海勋和医药科技有限公司 托拉塞米钠一水合物、其晶型及组合物
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE185374C (da) *
DE30681C (de) * R.W. traylor in Richmond, County of Henrico State of Virginia, V. St. A Gufsform aus Glimmer
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid

Also Published As

Publication number Publication date
AU7535587A (en) 1988-01-14
GR3000534T3 (en) 1991-07-31
JPS6323818A (ja) 1988-02-01
DE3623620A1 (de) 1988-01-21
DK360287A (da) 1988-01-13
FI87993C (fi) 1993-03-25
EP0253226B1 (de) 1990-06-06
DE3763010D1 (de) 1990-07-12
KR880001294A (ko) 1988-04-22
AU578562B2 (en) 1988-10-27
JPH055810B2 (da) 1993-01-25
DK174624B1 (da) 2003-07-28
EP0253226A1 (de) 1988-01-20
DE3623620C2 (da) 1991-02-28
KR950010158B1 (ko) 1995-09-11
CA1302278C (en) 1992-06-02
ATE53296T1 (de) 1990-06-15
US4861786A (en) 1989-08-29
FI87993B (fi) 1992-12-15
NZ221026A (en) 1989-09-27
FI873059A (fi) 1988-01-13
FI873059A0 (fi) 1987-07-10
ES2016306B3 (es) 1990-11-01

Similar Documents

Publication Publication Date Title
DK360287D0 (da) Sproejteklare, vandige, alkaliske injektionsoploesninger af torasemid og fremgangsmaade til fremstilling deraf
NZ334710A (en) Heterocycle derivatives which inhibit factor Xa attributed to strong anticoagulant and antithrombotic effect of compounds
AR245718A1 (es) Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina
NO166687C (no) Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.
AU3775685A (en) Xanthine derivatives
PT77110A (fr) Procede de preparation de nouveaux derives de la xanthine
EA199600024A2 (ru) Жидкая стабильная фармацевтическая композиция, содержащая уратоксидазу и лиофилизат для ее получения
ATE65084T1 (de) Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen.
GB1495289A (en) Pharmaceutically active proteinaceous compounds
FR2380782A1 (fr) Fraction 5 de thymosine stabilisee utile comme medicament et procede pour la preparer
ES2062015T3 (es) Soluciones inyectables.
DE59108859D1 (de) 3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel
ATE104149T1 (de) Dialysier- und spuelloesung zur intraperitonealen verarbreichung.
ES482818A1 (es) Un metodo para la produccion de una composicion farmaceuti- ca de una cefalosporina para administracion rectal.
KR860002269A (ko) 비경구용 액제의 제조방법
ES2061490T3 (es) Derivados de perhidrotiazepina y perhidroazepina, su preparacion y uso en terapeutica.
ES2053578T3 (es) Pirrolidinonas substituidas.
DK69287A (da) Temazepamkomposition og fremgangsmaade til fremstilling af samme
KR830003491A (ko) 치환된 6-아릴-4H-s-트리아졸로-〔3,4-c〕-티에노-〔2,3-e〕-1,4-디아제핀의 제조방법

Legal Events

Date Code Title Description
PUP Patent expired